Purchase Order VA25916E4057
Award Date 5/2/16
Potential Completion Date 9/30/16
Potential Value $84K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Deerfield, IL 60015, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
11
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Department of Veterans Affairs Veterans Health Administration (VHA) Veterans Integrated Service Network 19 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The order, valued at $149,274.24, is for the provision of pharmaceutical products to the VHA under the Pharmaceuticals and Drugs GSA Schedule contract. The order does not utilize any small business set-asides. Grifols, a well-established...
- This is a delivery order issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The $278,987.52 firm fixed price award is for the provision of unspecified DRUG products under the Pharmaceuticals and Drugs GSA Schedule contract. The order has a period of performance ending on March 15, 2017 and does not utilize a small business set-aside....
- This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $136,024.56 delivery order was issued under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and has a firm fixed price. The order is for the VA's Veterans Integrated Service Network 19 to procure pharmaceutical products, with a period of performance through September 30,...
- This federal contract award is a Blanket Purchase Agreement (BPA) call placed by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 with Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract, valued at $134,171.44, is for the delivery of unspecified medicines and is placed under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule. The contract does...
- This is a $93,183.36 firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the U.S. Department of Veterans Affairs to Grifols Therapeutics LLC, a manufacturer of pharmaceuticals and biopharmaceuticals. The contract is for the provision of the pharmaceutical product Prolastin to the Veterans Integrated Service Network 7 for the 2018 fiscal year. The contract was awarded on March 29, 2018 and has an ultimate completion date of September 30, 2018. This contract was not set...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call task order awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit pharmaceutical manufacturer. The award is for the express purpose of fulfilling pharmacy orders for pharmaceuticals for the VA during fiscal year 2017, with a potential value of $88,505.84 and a period of performance ending on September 30, 2017. The award is placed against the VA's Pharmaceuticals and Drugs GSA Schedule...
- This federal contract award is for a Blanket Purchase Agreement (BPA) call from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of Prolastin, a pharmaceutical product, with a potential value of $125,209.92. The contract does not utilize any small business set-asides and is a Firm Fixed...
- This federal contract award, valued at $161,280.00, was issued by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to the prime contractor Grifols Therapeutics LLC. The contract is a delivery order placed against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) held by Grifols. The award is for the provision of pharmaceutical medication, with no set-aside designation. Grifols Therapeutics LLC is a for-profit manufacturer and...
- This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $639,352.61 Blanket Purchase Agreement (BPA) call contract is for the delivery of medication, specifically pharmaceuticals and drugs, under the General Services Administration (GSA) Pharmaceuticals and Drugs Schedule. The contract does...
- This federal contract award was made by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the delivery of medication, specifically pharmaceuticals such as Prolastin, Prolastin-C, and immune globulin. The contract type is a Blanket Purchase Agreement (BPA) Call, with a Firm Fixed Price pricing structure. The...